These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 31689477)
41. Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study. Booth CM; Clemons M; Dranitsaris G; Joy A; Young S; Callaghan W; Trudeau M; Petrella T J Support Oncol; 2007 Sep; 5(8):374-80. PubMed ID: 17944146 [TBL] [Abstract][Full Text] [Related]
42. Reduction in nausea and vomiting in children undergoing cancer chemotherapy by either appropriate or sham auricular acupuncture points with standard care. Yeh CH; Chien LC; Chiang YC; Lin SW; Huang CK; Ren D J Altern Complement Med; 2012 Apr; 18(4):334-40. PubMed ID: 22515794 [TBL] [Abstract][Full Text] [Related]
43. The efficacy and cost effectiveness of new antiemetic guidelines. Engstrom C; Hernandez I; Haywood J; Lilenbaum R Oncol Nurs Forum; 1999 Oct; 26(9):1453-8. PubMed ID: 11064877 [TBL] [Abstract][Full Text] [Related]
44. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood. Phillips RS; Gopaul S; Gibson F; Houghton E; Craig JV; Light K; Pizer B Cochrane Database Syst Rev; 2010 Sep; (9):CD007786. PubMed ID: 20824866 [TBL] [Abstract][Full Text] [Related]
45. Acupressure for chemotherapy-induced nausea and vomiting: a randomized clinical trial. Dibble SL; Luce J; Cooper BA; Israel J; Cohen M; Nussey B; Rugo H Oncol Nurs Forum; 2007 Jul; 34(4):813-20. PubMed ID: 17723973 [TBL] [Abstract][Full Text] [Related]
46. Results of a compassionate-use program using intravenous ondansetron to prevent nausea and vomiting in patients receiving emetogenic cancer chemotherapy. Berry WR; House KW; Lee JT; Plagge PB; Meshad MW; Grapski R Semin Oncol; 1992 Dec; 19(6 Suppl 15):33-7. PubMed ID: 1485180 [TBL] [Abstract][Full Text] [Related]
47. Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysis. Donovan HS; Hagan TL; Campbell GB; Boisen MM; Rosenblum LM; Edwards RP; Bovbjerg DH; Horn CC Support Care Cancer; 2016 Jun; 24(6):2635-42. PubMed ID: 26746209 [TBL] [Abstract][Full Text] [Related]
48. A randomized study of olanzapine-containing versus standard antiemetic regimens for the prevention of chemotherapy-induced nausea and vomiting in Chinese breast cancer patients. Yeo W; Lau TK; Li L; Lai KT; Pang E; Cheung M; Chan VT; Wong A; Soo WM; Yeung VT; Tse T; Lam DC; Yeung EW; Ng KP; Tang NL; Tong M; Suen JJ; Mo FK Breast; 2020 Apr; 50():30-38. PubMed ID: 31978815 [TBL] [Abstract][Full Text] [Related]
49. Chemotherapy-Induced Neuropathy in Cancer Survivors. Miaskowski C; Mastick J; Paul SM; Topp K; Smoot B; Abrams G; Chen LM; Kober KM; Conley YP; Chesney M; Bolla K; Mausisa G; Mazor M; Wong M; Schumacher M; Levine JD J Pain Symptom Manage; 2017 Aug; 54(2):204-218.e2. PubMed ID: 28063866 [TBL] [Abstract][Full Text] [Related]
50. Controlling chemotherapy-induced nausea requires further improvement: symptom experience and risk factors among Korean patients. Rha SY; Park Y; Song SK; Lee CE; Lee J Support Care Cancer; 2016 Aug; 24(8):3379-89. PubMed ID: 26984242 [TBL] [Abstract][Full Text] [Related]
53. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis. Natale JJ Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912 [TBL] [Abstract][Full Text] [Related]
54. The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers. Ihbe-Heffinger A; Ehlken B; Bernard R; Berger K; Peschel C; Eichler HG; Deuson R; Thödtmann J; Lordick F Ann Oncol; 2004 Mar; 15(3):526-36. PubMed ID: 14998860 [TBL] [Abstract][Full Text] [Related]
55. Impact of worst pain severity and morning fatigue profiles on oncology outpatients' symptom burden and quality of life. Bouvron B; Mackin L; Kober KM; Paul SM; Cooper BA; Conley YP; Hammer MJ; Wright F; Levine JD; Miaskowski C Support Care Cancer; 2022 Dec; 30(12):9929-9944. PubMed ID: 36355215 [TBL] [Abstract][Full Text] [Related]
56. Impact of cancer-related fatigue on chemotherapy-induced nausea and vomiting in Asian cancer patients. Poon KS; Un MK; Low XH; Cheung YT; Yap KY; Chan A Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1345-51. PubMed ID: 24023040 [TBL] [Abstract][Full Text] [Related]
57. Longitudinal Association of Poor Sleep Quality With Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer. Jung D; Lee KM; Kim WH; Lee JY; Kim TY; Im SA; Lee KH; Spiegel D; Hahm BJ Psychosom Med; 2016 Oct; 78(8):959-965. PubMed ID: 27428859 [TBL] [Abstract][Full Text] [Related]
58. Chemotherapy-induced nausea and vomiting is less controlled at delayed phase in patients with esophageal cancer: a prospective registration study by the CINV Study Group of Japan. Baba Y; Baba H; Yamamoto S; Shimada H; Shibata T; Miyazaki T; Yoshikawa T; Nakajima Y; Tsuji Y; Shimokawa M; Kitagawa Y; Aiba K Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 27001532 [TBL] [Abstract][Full Text] [Related]
59. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience. Sorbe BG Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123 [TBL] [Abstract][Full Text] [Related]
60. Options for the prevention and management of acute chemotherapy-induced nausea and vomiting in children. Dupuis LL; Nathan PC Paediatr Drugs; 2003; 5(9):597-613. PubMed ID: 12956617 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]